Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -42.10%30.71B | -23.81%37.92B | -67.38%9.82B | 3.43%163.35B | 10.95%30.42B | -0.71%53.04B | -13.47%49.77B | 53.87%30.12B | 15.84%157.93B | -45.45%27.42B |
Net profit before non-cash adjustment | -26.39%38.91B | 43.45%61.43B | -24.57%54.24B | -10.39%125.93B | -160.39%-41.66B | -5.37%52.86B | -1.46%42.83B | 25.70%71.9B | 3.73%140.53B | -265.90%-16B |
Total adjustment of non-cash items | 269.14%12.21B | -7.84%-9.47B | 13.13%-9.15B | 177.37%27.85B | 44.12%54.38B | -57.45%-7.22B | 1.42%-8.78B | 25.82%-10.54B | 93.95%10.04B | 51.92%37.73B |
-Depreciation and amortization | 28.39%2.52B | -2.75%2.47B | 37.30%2.42B | 27.06%8.6B | 44.15%2.33B | 13.94%1.96B | 54.09%2.54B | -0.84%1.76B | -20.09%6.77B | -8.13%1.62B |
-Reversal of impairment losses recognized in profit and loss | -80.74%68M | -25.44%214M | 500.49%6.16B | 789.36%47.47B | 2,975.82%45.8B | -74.57%353M | -87.07%287M | 325.73%1.03B | 81.47%5.34B | -47.20%1.49B |
-Share of associates | 329.50%1.06B | 48.26%2.51B | 2.28%761M | -65.74%3.51B | -3.88%1.54B | -107.92%-461M | 8.75%1.69B | -41.46%744M | 925.63%10.25B | 106.73%1.6B |
-Disposal profit | -4,918.75%-3.21B | -116.44%-3.96B | -8.91%-3.48B | -271.85%-10.97B | -166.37%-5.87B | 87.30%-64M | -146.14%-1.83B | 46.12%-3.2B | 324.84%6.38B | 3,378.15%8.85B |
-Net exchange gains and losses | 372.16%15.7B | 5.32%-5.68B | -95.95%-8.12B | 61.53%-6.63B | -68.84%9.28B | 52.62%-5.77B | 73.51%-6B | 66.05%-4.15B | -72.03%-17.24B | 55.82%29.79B |
-Remuneration paid in stock | -43.11%834M | -39.63%923M | 48.42%797M | -54.72%4.39B | -53.55%856M | -42.53%1.47B | -40.71%1.53B | -80.24%537M | -7.78%9.69B | -48.32%1.84B |
-Other non-cash items | -1.10%-4.76B | 15.12%-5.94B | -5.84%-7.69B | -66.20%-18.52B | 106.05%451M | -38.90%-4.71B | -494.42%-7B | -250.85%-7.27B | -128.32%-11.14B | -154.51%-7.46B |
Changes in working capital | -375.58%-20.4B | -189.41%-14.05B | -12.85%-35.26B | 30.01%9.58B | 211.38%17.7B | 245.01%7.4B | -31.53%15.72B | -33.41%-31.25B | 270.60%7.37B | -63.98%5.69B |
-Change in receivables | -291.28%-29.07B | -188.27%-21.59B | 37.53%-20.13B | 49.64%-4.52B | 151.77%10.69B | -3.05%-7.43B | 10.85%24.45B | -14.84%-32.23B | -286.21%-8.97B | -76.56%4.25B |
-Change in payables | -331.32%-4.29B | 128.38%821M | 163.07%1.83B | -76.86%946M | -18.48%1.29B | 44.13%1.86B | -291.47%-2.89B | -64.51%696M | 378.92%4.09B | 323.16%1.58B |
-Provision for loans, leases and other losses | 8.88%9.83B | 1,633.41%7.78B | -79.15%-11.18B | 66.87%6.96B | -7.19%3.73B | 305.21%9.02B | -77.88%449M | -52.07%-6.24B | 451.18%4.17B | 70.59%4.02B |
-Changes in other current assets | -5.56%1.99B | 272.85%3.14B | -548.91%-7.2B | -49.65%2.87B | 133.34%978M | -51.14%2.11B | -189.77%-1.82B | -30.36%1.6B | 212.02%5.7B | -35.72%-2.93B |
-Changes in other current liabilities | -38.26%1.14B | 5.90%-4.21B | -71.24%1.42B | 39.75%3.31B | 182.80%1.02B | 20.71%1.85B | -85.15%-4.48B | 9.81%4.92B | 270.63%2.37B | 32.36%-1.23B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | 743M | 0.59%1.86B | 39.52%759M | 1.85B | 544M | |||||
Interest paid (cash flow from operating activities) | -41.30%-544M | -74.59%-536M | -49.83%-448M | -140.17%-1.41B | -77.68%-414M | -205.56%-385M | -153.72%-307M | -184.76%-299M | -40.96%-585M | -111.82%-233M |
Interest received (cash flow from operating activities) | -8.32%6.22B | -6.12%4.24B | 50.28%4.9B | 68.28%20.94B | 54.54%6.38B | 138.56%6.79B | 26.61%4.51B | 71.05%3.26B | 63.99%12.44B | 262.97%4.13B |
Tax refund paid | 45.84%-8.64B | 20.02%-21.35B | 43.96%-2.85B | -36.65%-54.17B | -48.52%-6.44B | -39.02%-15.95B | -30.15%-26.69B | -53.02%-5.09B | -5.46%-39.64B | 34.17%-4.33B |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating cash flow | -30.67%28.5B | -24.04%22.13B | -57.30%12.18B | -1.10%128.71B | 11.00%29.95B | -7.98%41.1B | -27.99%29.13B | 58.10%28.53B | 22.88%130.14B | -39.66%26.98B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 18.86%-641M | -10.22%-949M | -79.16%-808M | -25.55%-3.37B | -86.43%-1.26B | 24.98%-790M | -57.98%-861M | -11.36%-451M | -76.73%-2.68B | -30.89%-678M |
Net intangibles purchase and sale | -868.52%-523M | 28.55%-483M | 48.33%-681M | 25.64%-2.31B | -19.44%-258M | 94.02%-54M | 62.53%-676M | -640.45%-1.32B | 75.27%-3.1B | 65.16%-216M |
Net business purchase and sale | -1,069.88%-4.74B | --0 | 91.42%-2.02B | -36.34%-26.5B | -87.64%-2.6B | -1,406.45%-405M | 100.03%7M | -1,171.87%-23.51B | 63.07%-19.44B | 97.37%-1.38B |
Net investment product transactions | 302.19%80.3B | 80.72%-12.02B | 52.24%-40.46B | -756.08%-143.98B | 195.24%42.81B | -245.37%-39.72B | -255.83%-62.35B | -19,332.11%-84.72B | -75.27%21.95B | 35.49%-44.95B |
Advance cash and loans provided to other parties | 144.93%696M | 47.11%-804M | -3.56%-1.57B | -37.68%-6.16B | -7.61%-1.57B | -6.75%-1.55B | -832.52%-1.52B | -8.51%-1.52B | 75.19%-4.47B | -3,071.74%-1.46B |
Repayment of advance payments to other parties and cash income from loans | 25.00%5M | -80.00%3M | 0.00%4M | -86.83%27M | -63.64%4M | -76.47%4M | -91.23%15M | -33.33%4M | -98.77%205M | -79.25%11M |
Net changes in other investments | -607.27%-1.56B | -275.55%-8.3B | 137.19%228M | -80.33%-6.09B | -168.84%-3.05B | -94.69%-220M | -153.33%-2.21B | 51.27%-613M | -31.06%-3.38B | -6.59%-1.13B |
Investing cash flow | 272.11%73.54B | 66.64%-22.55B | 59.59%-45.31B | -1,625.29%-188.37B | 168.42%34.08B | -279.18%-42.73B | -509.18%-67.59B | -7,491.47%-112.13B | -160.37%-10.92B | 60.00%-49.81B |
Financing cash flow | ||||||||||
Net common stock issuance | 10.41%-9.63B | -664.28%-19.34B | 75.31%-6.73B | ---- | ---- | -870.54%-10.75B | 96.06%-2.53B | -56.30%-27.25B | ---- | ---- |
Increase or decrease of lease financing | -21.47%-1.08B | -30.80%-1.1B | -37.45%-1.05B | ---- | ---- | -14.05%-885M | -12.28%-841M | -5.26%-761M | ---- | ---- |
Cash dividends paid | -42.36%-6.08B | ---105M | 4.62%-4.11B | ---- | ---- | 1.25%-4.27B | --0 | 3.34%-4.31B | ---- | ---- |
Net other fund-raising expenses | --31M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Financing cash flow | -5.33%-16.75B | -509.13%-20.54B | 63.23%-11.88B | ---- | ---- | -329.20%-15.91B | 94.81%-3.37B | -42.91%-32.31B | ---- | ---- |
Net cash flow | ||||||||||
Beginning cash position | -12.21%230.02B | -16.26%244.23B | -31.48%280.52B | ---- | ---- | -33.78%262.01B | -22.45%291.67B | 12.08%409.37B | ---- | ---- |
Current changes in cash | 586.40%85.29B | 49.88%-20.97B | 61.17%-45B | -150.04%-59.66B | 68.88%115.62B | -127.05%-17.53B | -422.51%-41.83B | -1,818.99%-115.91B | 15.82%119.23B | 171.37%68.46B |
Effect of exchange rate changes | -423.36%-18.44B | -44.48%6.76B | 585.24%8.72B | ---- | ---- | 10,101.75%5.7B | -55.87%12.18B | -110.63%-1.8B | ---- | ---- |
End cash Position | 18.67%296.87B | -12.21%230.02B | -16.26%244.23B | ---- | ---- | -45.67%250.18B | -33.78%262.01B | -22.45%291.67B | ---- | ---- |
Free cash flow | -32.12%27.32B | -25.12%20.65B | -60.07%10.68B | -1.00%123B | 9.08%28.41B | -5.73%40.25B | -27.51%27.58B | 53.29%26.76B | 35.36%124.24B | -40.21%26.05B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |